The HLA-DRB109:01-DQB103:03 haplotype is associated with the risk for late-onset Alzheimer’s disease in APOE $${\varepsilon }}$$ ε 4–negative Japanese adults

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: The HLA-DRB1*09:01-DQB1*03:03 haplotype is associated with the risk for late-onset Alzheimer’s disease in APOE $${\varepsilon }}$$ ε 4–negative Japanese adults ; volume:10 ; number:1 ; day:2 ; month:1 ; year:2024 ; pages:1-7 ; date:12.2024
npj aging ; 10, Heft 1 (2.1.2024), 1-7, 12.2024

Creator: Shigemizu, Daichi
Fukunaga, Koya
Yamakawa, Akiko
Suganuma, Mutsumi
Fujita, Kosuke
Kimura, Tetsuaki
Watanabe, Ken
Mushiroda, Taisei
Sakurai, Takashi
Niida, Shumpei
Ozaki, Kouichi

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41514-023-00131-3

URN: urn:nbn:de:101:1-2024031509511437870617

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:55 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Shigemizu, Daichi
Fukunaga, Koya
Yamakawa, Akiko
Suganuma, Mutsumi
Fujita, Kosuke
Kimura, Tetsuaki
Watanabe, Ken
Mushiroda, Taisei
Sakurai, Takashi
Niida, Shumpei
Ozaki, Kouichi
SpringerLink (Online service)

Other Objects (12)

Identifying genetic interactions associated with late-onset Alzheimer’s disease

Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups

Early and late-onset Alzheimer’s disease: What are the differences?

A retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer’s disease

Late-onset Alzheimer’s disease is associated with inherent changes in bioenergetics profiles

Evaluation of Animal Models by Comparison with Human Late-Onset Alzheimer’s Disease

Benchmarking machine learning models for late-onset alzheimer’s disease prediction from genomic data

Endo-lysosomal dysregulations and late-onset Alzheimer’s disease: impact of genetic risk factors

Medial temporal lobe atrophy patterns in early-versus late-onset amnestic Alzheimer’s disease

Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer’s Disease

Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer’s disease mice

A novel systems biology approach to evaluate mouse models of late-onset Alzheimer’s disease

Identifying genetic interactions associated with late-onset Alzheimer’s disease

Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups

Early and late-onset Alzheimer’s disease: What are the differences?

A retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer’s disease

Late-onset Alzheimer’s disease is associated with inherent changes in bioenergetics profiles

Evaluation of Animal Models by Comparison with Human Late-Onset Alzheimer’s Disease

Benchmarking machine learning models for late-onset alzheimer’s disease prediction from genomic data

Endo-lysosomal dysregulations and late-onset Alzheimer’s disease: impact of genetic risk factors

Medial temporal lobe atrophy patterns in early-versus late-onset amnestic Alzheimer’s disease

Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer’s Disease

Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer’s disease mice

A novel systems biology approach to evaluate mouse models of late-onset Alzheimer’s disease

Identifying genetic interactions associated with late-onset Alzheimer’s disease

Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups

Early and late-onset Alzheimer’s disease: What are the differences?

A retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer’s disease

Late-onset Alzheimer’s disease is associated with inherent changes in bioenergetics profiles

Evaluation of Animal Models by Comparison with Human Late-Onset Alzheimer’s Disease

Benchmarking machine learning models for late-onset alzheimer’s disease prediction from genomic data

Endo-lysosomal dysregulations and late-onset Alzheimer’s disease: impact of genetic risk factors

Medial temporal lobe atrophy patterns in early-versus late-onset amnestic Alzheimer’s disease

Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer’s Disease

Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer’s disease mice

A novel systems biology approach to evaluate mouse models of late-onset Alzheimer’s disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

The HLA-DRB1*09:01-DQB1*03:03 haplotype is associated with the risk for late-onset Alzheimer’s disease in APOE $${\varepsilon }}$$ ε 4–negative Japanese adults

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Identifying genetic interactions associated with late-onset Alzheimer’s disease

Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups

Early and late-onset Alzheimer’s disease: What are the differences?

A retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer’s disease

Late-onset Alzheimer’s disease is associated with inherent changes in bioenergetics profiles

Evaluation of Animal Models by Comparison with Human Late-Onset Alzheimer’s Disease

Benchmarking machine learning models for late-onset alzheimer’s disease prediction from genomic data

Endo-lysosomal dysregulations and late-onset Alzheimer’s disease: impact of genetic risk factors

Medial temporal lobe atrophy patterns in early-versus late-onset amnestic Alzheimer’s disease

Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer’s Disease

Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer’s disease mice

A novel systems biology approach to evaluate mouse models of late-onset Alzheimer’s disease

Identifying genetic interactions associated with late-onset Alzheimer’s disease

Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups

Early and late-onset Alzheimer’s disease: What are the differences?

A retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer’s disease

Late-onset Alzheimer’s disease is associated with inherent changes in bioenergetics profiles

Evaluation of Animal Models by Comparison with Human Late-Onset Alzheimer’s Disease

Benchmarking machine learning models for late-onset alzheimer’s disease prediction from genomic data

Endo-lysosomal dysregulations and late-onset Alzheimer’s disease: impact of genetic risk factors

Medial temporal lobe atrophy patterns in early-versus late-onset amnestic Alzheimer’s disease

Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer’s Disease

Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer’s disease mice

A novel systems biology approach to evaluate mouse models of late-onset Alzheimer’s disease

Identifying genetic interactions associated with late-onset Alzheimer’s disease

Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups

Early and late-onset Alzheimer’s disease: What are the differences?

A retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer’s disease

Late-onset Alzheimer’s disease is associated with inherent changes in bioenergetics profiles

Evaluation of Animal Models by Comparison with Human Late-Onset Alzheimer’s Disease

Benchmarking machine learning models for late-onset alzheimer’s disease prediction from genomic data

Endo-lysosomal dysregulations and late-onset Alzheimer’s disease: impact of genetic risk factors

Medial temporal lobe atrophy patterns in early-versus late-onset amnestic Alzheimer’s disease

Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer’s Disease

Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer’s disease mice

A novel systems biology approach to evaluate mouse models of late-onset Alzheimer’s disease

Related objects

Reset password

The HLA-DRB109:01-DQB103:03 haplotype is associated with the risk for late-onset Alzheimer’s disease in APOE $${\varepsilon }}$$ ε 4–negative Japanese adults